AbCellera Biologics Inc. (ABCL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.02B |
| Enterprise Value | 1.04B |
| P/E Ratio | -20.96 |
| PEG Ratio | 38.59 |
| Price/Sales Ratio | 52.24 |
| Price/Book Ratio | 3.86 |
| Enterprise/Revenue | 52.47 |
| Enterprise/EBITDA | -21.66 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -2.49 |
| Operating Margin | -3.4 |
| Return On Assets | -0.13 |
| Return On Equity | -0.17 |
| Revenue | 75.13M |
| Revenue/Share | 0.22 |
| Gross Profit | 46.31M |
| EBITDA | -148.77M |
| Net Income | -146.41M |
| Diluted EPS | -0.49 |
| Total Cash | 540.1M |
| Total Cash/Share | 1.77 |
| Total Debt | 135.62M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 12.77 |
| Book Value Per Share | 2.93 |
| 52-Week Change | 157.86 |
| 52-Week High | 12.15 |
| 52-Week Low | 2.75 |
| Moving Average 50 Days | 7.21 |
| Moving Average 200 Days | 4.76 |
| Average Volume | 8.02M |
| Shares Outstanding | 305.38M |
| % Held by Institutions | 41.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |